# Global Blood Glucose Test Strip Market

> Blood Glucose Test Strip Market Research Report: Size, Share, Trend Analysis By Technology (Thick Film Electrochemical, Thin Film Electrochemical, Optical)) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.04%
- **2024:** $ 6.25 Billion
- **2025:** $ 6.56 Billion
- **2035:** $ 10.73 Billion
- **Key Players:** Companies such as Abbott (US), Roche (CH), Bayer (DE), Dexcom (US), Terumo (JP), Ascensia Diabetes Care (DE), LifeScan (US), Nova Biomedical (US), Acon Laboratories (US) are some of the major participants in the global market.

**Report ID:** MRFR/MED/0470-CR · **Pages:** 80 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** May 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/global-blood-glucose-test-strip-market-976

---

## Market Summary

## **Blood Glucose Test Strip Market Overview**

The Blood Glucose Test Strip Market Size was valued at USD 7.05 Billion in 2023. The Blood Glucose Test Strip industry is projected to grow from USD 7.69 Billion in 2025 to USD 10.73 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.04% during the forecast period (2025 - 2035). 

Blood glucose test strip are small disposable strip that are used in conjunction with blood glucose meters for monitoring and controlling diabetes. These strip have glucose oxidase impregnated on them, which when reacts with glucose present in the blood produces gluconic acid. For this, a thin paper or plastic strip called blood glucose test strip are employed to check blood glucose levels and assist in managing diabetes.

In the medical diagnostics industry, diabetes test strip are indispensable, particularly for blood sugar monitoring and urinalysis. Test strip are composed of several strata, which comprise hydrophilic inner, adhesive, and electrode layers, in addition to a stable outer layer. Such diabetic blood test strip enable diabetic patients to effectively manage their condition by monitoring and regulating their glucose levels. Prediabetics and diabetics can routinely monitor their blood sugar levels without having to attend a clinic or diagnostic laboratory by using test strip.

Apart from this, urine test strip play a vital role in medical diagnostics, specifically in the detection of urinary tract infections and the monitoring of kidney function. The test strip are capable of identifying a range of substances, including proteins, glucose, and ketones, in the urine.

## **Blood Glucose Test Strip Market Trends**

### **Utilization of Point-of-care testing for diabetes is a growing trend shaping the market and creating new opportunities.**

The Blood Glucose test strip market is poised to experience substantial expansion due to the growing trend of utilizing point-of-care testing.

Point-of-care testing enables immediate, on-site analyses of blood glucose levels to be performed, eliminating the necessity for laboratory processing and ensuring the provision of accurate, timely results. There are numerous advantages associated with this methodology, encompassing convenience, expedited response times, and immediate modifications in strategies for managing diabetes. The capacity of point-of-care testing to provide prompt and accurate results is the reason for its widespread use. The conventional approach to laboratory testing may entail extended waiting periods for results, thereby impeding the ability to make prompt decisions concerning the management of diabetes.

With the one-touch blood glucose test strip, patients can have their blood glucose levels assessed at the point of care facilities within minutes. If necessary, they can make immediate adjustments to their nutrition, exercise regimen, or medication. This form of feedback enables individuals diagnosed with diabetes to effectively self-manage their condition and promptly make informed decisions regarding their health.

Point-of-care testing facility not only offers convenience and efficiency but also provide practical advantages for healthcare providers and medical institutions. It provides healthcare professionals with vital information regarding diagnosis, therapy adjustments, and monitoring of patients' blood glucose levels during clinic visits. Point-of-care tests streamline processes, enhance the efficiency of patient care, and eliminate the need for laboratory referrals. Healthcare facilities, including hospitals, clinics, and ambulatory surgical centres, are progressively incorporating point-of-care testing into their established clinical practices to enhance the patient experience and optimise healthcare delivery.

## **Blood Glucose Test Strip Market Segment Insights**

The Blood Glucose test strip market is primarily segmented by technology, product type, and end-user insights.

### **Blood Glucose Test Strip Technology Insights**

The blood glucose test strip market when segmented based on technological insights, is further bifurcated into electrochemical, enzymatic and colourimetric, where the electrochemical sub-segment owns the larger portion of the market share, due to the high accuracy it offers and the ease of testing that such electrochemical strip offer.

### **Blood Glucose Test Strip Product Type Insights**

The blood glucose test strip market when segmented based on product types, is further divided into blood test strip and urine test strip, where the blood test strip accumulate the larger market share and is also anticipated to register a higher CAGR during the forecast period 2025 to 2035. The Easy-Touch glucose test strip quantify the concentration of glucose in a finger puncture of blood. By inserting the test strip into a blood glucose meter, the quantity of glucose in the blood sample is determined.

By observing the data presented on the screen of the meter, the patient can monitor the evolution of their blood sugar levels.

### **Blood Glucose Test Strip End-User Insights**

Based on  End-User segmentation, the blood glucose test strip market is further divided into hospitals, diagnostics centres, nursing homes and others. Out of these, the hospital sub-segmentation owes the major market share. In addition, purchasing groups are utilized by hospitals and clinics to acquire test strip in quantity. Since the inception of the COVID-19 pandemic, these devices have been the most frequently employed in public and private settings to identify hyperglycaemia, hypoglycaemia, and glycaemic variations.

### **Blood Glucose Test Strip Regional Insights**

The Blood Glucose test strip market is primarily studied across four major reasons namely, North America, Europe, Asia-Pacific and the Rest of the World. Among these prominent regions, the North American region holds the major market share of the said market segment, and the Asia-Pacific region is said to have the highest CAGR during the forecast period.

Several factors are driving the North American market forward which include the rising incidence of diabetes, the initiatives of the national government to combat the disease more broadly, the rising prevalence of test strip, and the presence of significant market players. The United States is anticipated to retain the largest market share in North America. According to data updated by the CDC in January 2022, diabetes affected 37.3 million individuals, or 11.3%, of the US population. In the previous year, the disease affected 28.7 million people, including 28.5 million adults, in the country.

It is anticipated that this demographic will propel the demand for diabetes test strip and stimulate regional market expansion.

The Europe test strip market holds the second largest market share as a result of the region's high prevalence of chronic diseases and the government's increasing support, which is demonstrated through increased investments in the construction of hospitals equipped with modern technology. Furthermore, it was reported that the German market held the largest proportion of the test strip industry, while the United Kingdom market is regarded as the most rapidly expanding market in Europe.

Apart from these two regions, the Asia-Pacific region is said to be the fastest-growing region with the highest CAGR during the period of forecast. The significant increase in diabetes prevalence among the APAC nations is a key driver of market revenue expansion. Based on data from the IDF Atlas, the prevalence of diabetes in India was estimated to be at 92.9 million by 2032, up from 74.1 million in 2021.

## **Blood Glucose Test Strip Market Key Players & Competitive Insights**

The Blood Glucose test strip market is moderately fragmented, with several significant companies operating at both the international and regional levels. To strengthen their positions in the global market and develop their respective portfolios, key players in the market are conducting clinical trials and developing products and medical devices, as well as forming strategic alliances and agreements with global leaders in the said domains. Dario Health Corporation, LifeScan, Inc., ARKRAY, Inc., Medtronic plc, Bionime Corporation, and Care Touch LLC are among the key companies profiled in the said market segment.

## **Blood Glucose Test Strip Market Key Companies**

### Global Blood Glucose Test Strip Market Industry Developments

- **Q2 2024: Ascensia Diabetes Care Launches Next-Generation CONTOUR®NEXT Blood Glucose Test Strips in the U.S.** Ascensia Diabetes Care announced the U.S. launch of its next-generation CONTOUR®NEXT blood glucose test strips, designed to deliver improved accuracy and ease of use for people with diabetes.
- **Q1 2024: Trividia Health Announces FDA Clearance for TRUE METRIX® AIR Blood Glucose Test Strips** Trividia Health received FDA clearance for its TRUE METRIX® AIR blood glucose test strips, expanding its portfolio of diabetes management solutions in the U.S. market.
- **Q2 2024: ARKRAY, Inc. Opens New Manufacturing Facility for Blood Glucose Test Strips in Minnesota** ARKRAY, Inc. inaugurated a new manufacturing facility in Minnesota to increase production capacity for its blood glucose test strips, aiming to meet growing demand in North America.
- **Q3 2024: Roche Receives CE Mark for Accu-Chek Guide Me Blood Glucose Test Strips in Europe** Roche announced it has received CE Mark approval for its Accu-Chek Guide Me blood glucose test strips, enabling commercialization across the European Union.
- **Q1 2024: BioSense Medical Secures $20 Million Series B Funding to Expand Blood Glucose Test Strip Production** BioSense Medical closed a $20 million Series B funding round to scale up manufacturing and accelerate development of its next-generation blood glucose test strips.
- **Q2 2025: AgaMatrix Announces Strategic Partnership with Medtronic for Blood Glucose Test Strip Distribution** AgaMatrix entered a strategic partnership with Medtronic to distribute its blood glucose test strips through Medtronic’s diabetes care network in select international markets.
- **Q1 2025: PTS Diagnostics Appoints New CEO to Drive Growth in Blood Glucose Test Strip Business** PTS Diagnostics announced the appointment of a new Chief Executive Officer, aiming to strengthen its leadership and accelerate growth in the blood glucose test strip segment.
- **Q2 2024: Bionime Corporation Launches Rightest GM7000 Blood Glucose Test Strips in India** Bionime Corporation launched its Rightest GM7000 blood glucose test strips in the Indian market, expanding its presence in Asia and offering advanced diabetes monitoring solutions.
- **Q3 2024: Ypsomed Receives FDA Clearance for mylife Unio Neva Blood Glucose Test Strips** Ypsomed received FDA clearance for its mylife Unio Neva blood glucose test strips, allowing the company to market the product in the United States.
- **Q1 2025: Dexcom Acquires Minority Stake in Blood Glucose Test Strip Startup GlucoTrack** Dexcom acquired a minority equity stake in GlucoTrack, a startup developing innovative blood glucose test strip technology, to support product development and potential future collaboration.
- **Q2 2025: Sinocare Receives NMPA Approval for Safe AQ Voice Blood Glucose Test Strips in China** Sinocare announced it has received approval from the National Medical Products Administration (NMPA) for its Safe AQ Voice blood glucose test strips, enabling commercial launch in China.
- **Q3 2024: Nova Biomedical Expands Blood Glucose Test Strip Production with New Facility in Ireland** Nova Biomedical opened a new manufacturing facility in Ireland to expand production capacity for its blood glucose test strips, supporting growth in the European market.

## Market Drivers

### Increasing Prevalence of Diabetes

The rising incidence of diabetes worldwide is a primary driver for The Global Blood Glucose Test Strip Industry. According to recent statistics, the number of individuals diagnosed with diabetes has surged, with estimates suggesting that over 500 million people are currently living with the condition.
 
This alarming trend necessitates regular monitoring of blood glucose levels, thereby propelling the demand for test strips. As healthcare systems strive to manage this chronic disease effectively, the need for accessible and reliable testing solutions becomes paramount. Consequently, manufacturers are focusing on developing innovative test strips that cater to the growing population of diabetic patients, which is likely to further stimulate market growth.

### Expansion of Home Healthcare Services

The expansion of home healthcare services is significantly impacting The Global Blood Glucose Test Strip Industry. As more patients prefer to manage their health conditions from the comfort of their homes, the demand for home monitoring devices, including blood glucose test strips, is on the rise.
 
This shift is driven by the convenience and flexibility that home healthcare offers, allowing patients to monitor their glucose levels without frequent visits to healthcare facilities. Furthermore, the increasing aging population, which often requires ongoing diabetes management, is likely to further fuel this trend. As a result, manufacturers are adapting their product offerings to meet the needs of this growing segment.

### Growing Awareness of Diabetes Management

There is a notable increase in awareness regarding diabetes management and the importance of regular blood glucose monitoring. Educational campaigns and initiatives by health organizations are contributing to this trend, thereby influencing The Global Blood Glucose Test Strip Industry.
 
As individuals become more informed about the risks associated with uncontrolled blood sugar levels, the demand for test strips is likely to rise. This heightened awareness is particularly evident in emerging markets, where healthcare access is improving, and patients are seeking effective tools for managing their condition. Consequently, this trend may lead to a sustained increase in market demand.

### Technological Innovations in Test Strips

Technological advancements play a crucial role in shaping The Global Blood Glucose Test Strip Industry. Innovations such as the development of non-invasive testing methods and smart test strips that integrate with mobile applications are gaining traction.
 
These advancements not only enhance the user experience but also improve the accuracy and reliability of glucose monitoring. For instance, the introduction of test strips that require smaller blood samples has made testing more convenient for patients. As a result, the market is witnessing a shift towards more sophisticated and user-friendly products, which could potentially attract a broader consumer base and drive sales.

### Integration with Digital Health Solutions

The integration of blood glucose test strips with digital health solutions is emerging as a key driver in The Global Blood Glucose Test Strip Industry. The proliferation of mobile health applications and wearable devices has created opportunities for seamless data tracking and management. Patients can now easily log their glucose levels, receive real-time feedback, and share data with healthcare providers.
 
This connectivity not only enhances patient engagement but also facilitates better disease management. As technology continues to evolve, the market is expected to see an increase in demand for test strips that are compatible with these digital platforms, potentially leading to improved health outcomes for users.

## Future Outlook

The Global Blood Glucose Test Strip Market size is projected to reach USD 10.73 Billion by 2035, growing at a CAGR of 5.04%

**New opportunities:**

- Development of smart glucose monitoring devices with integrated [test strips](https://www.marketresearchfuture.com/reports/test-strip-market-672). Expansion into emerging markets with tailored pricing strategies. Partnerships with telehealth platforms for remote patient monitoring solutions.

By 2035, the market is expected to achieve robust growth, solidifying its position as a vital component of diabetes management.

## Segment Insights

### By Application: Self Monitoring (Largest) vs. Point of Care (Fastest-Growing)

In the Global Blood Glucose Test Strip Market, the application segment is led by Self Monitoring, which dominates the share, accounting for 68% of the market share, due to the increasing prevalence of diabetes and rising awareness among patients toward managing their health. This segment benefits from a growing base of consumers who prefer convenient, home-based testing solutions, leading to a robust demand for self-monitoring devices. Following this, Point of Care is emerging as a significant sector, driven by the need for immediate diagnostic results in clinical settings and patient-centric healthcare services.

Self Monitoring (Dominant) vs. Point of Care (Emerging)

Self Monitoring remains the dominant application in The Global Blood Glucose Test Strip, primarily because of its resonance with diabetes patients who seek easy and frequent glucose monitoring at home. This segment is characterized by user-friendly devices that facilitate regular tracking of blood sugar levels, contributing to better management of diabetes. On the other hand, the Point of Care segment is rapidly gaining traction, driven by advancements in medical technologies that enable quicker test results in clinical environments. This segment appeals to healthcare professionals and institutions that require fast, efficient testing capabilities, underlining a shift towards more integrated patient care solutions in diverse medical settings.

### By End Use: Diabetes Management (Largest) vs. Obesity Management (Fastest-Growing)

The Global Blood Glucose Test Strip Market has seen a predominant share attributed to Diabetes Management, accounting for 31% of the market share, as it encompasses a vast user base and consistent demand driven by the rising prevalence of diabetes globally. Obesity Management, while currently a smaller segment, is gaining traction due to increasing health consciousness and rising obesity rates, signaling a pivotal shift in consumer awareness and healthcare strategies. As the focus on preventive healthcare intensifies, these trends are projected to shape future market dynamics significantly.

Diabetes Management: Dominant vs. Obesity Management: Emerging

Diabetes Management continues to dominate The Global Blood Glucose Test Strip, underscoring the critical need for continuous glucose monitoring among diabetes patients worldwide. The technology employed in these strips has seen significant advancements, allowing for faster and more accurate readings, which are essential for managing diabetes effectively. In contrast, Obesity Management is emerging as a vital focus area, reflecting a growing trend towards early intervention and preventative measures. Companies are innovating solutions that not only cater to diabetes but also address lifestyle-related concerns, reinforcing a proactive approach to health management.

### By Distribution Channel: Pharmacies (Largest) vs. Online Retail (Fastest-Growing)

In the Global Blood Glucose Test Strip Market, distribution channels exhibit diverse dynamics, with pharmacies holding the largest share, accounting for 56% of the market share, benefiting from their established presence and accessibility for consumers. They are often the first point of contact for patients who need diabetes management supplies. Following pharmacies, online retail channels have been gaining traction, becoming increasingly popular due to convenience and the rise of e-commerce.

Pharmacies: Dominant vs. Online Retail: Emerging

Pharmacies dominate the distribution of blood glucose test strips, leveraging their physical presence to provide immediate access to consumers. This channel is characterized by a broad range of product availability and the ability to consult pharmacists for personalized advice. On the other hand, online retail has emerged as a significant growth driver in recent years. This channel's success is attributed to increasing consumer preference for online shopping, competitive pricing, and the ability to provide discreet and convenient purchasing options. While pharmacies continue to lead, online retail is quickly capturing a larger market share, driven by technological advancements and changing consumer behaviors.

### By Product Type: Standard Test Strips (Largest) vs. Smart Test Strips (Fastest-Growing)

In the Global Blood Glucose Test Strip Market, Standard Test Strips hold the largest share, accounting for 72% of the market share, catering to a significant portion of users who rely on traditional glucose monitoring techniques. These strips have established their place in the market due to their reliable performance and cost-effectiveness, making them a preferred choice among many diabetic patients. In contrast, Smart Test Strips are rapidly gaining traction, driven by technological advancements and increasing acceptance of digital health solutions, which makes them the fastest-growing segment in the market.

Standard Test Strips (Dominant) vs. Smart Test Strips (Emerging)

Standard Test Strips remain the dominant product type in The market share, characterized by their widespread use and proven efficacy in [blood glucose monitoring](https://www.marketresearchfuture.com/reports/blood-glucose-monitoring-market-557). These strips are typically designed for use with standard glucose meters, providing reliable results and ease of use. On the other hand, Smart Test Strips represent an emerging trend that integrates advanced technology, enabling users to connect with mobile applications for data tracking and real-time insights. This innovation enhances user experience and offers additional functionalities, making Smart Test Strips highly attractive for tech-savvy patients.

## Regional Market Share Analysis

### North America : Market Leader in Innovation

North America leads in the Global Blood Glucose Test Strip Market Size, accounting for over 44.80% of the global revenue in 2024. The region's growth is driven by increasing diabetes prevalence, technological advancements, and supportive healthcare policies. Regulatory bodies are promoting innovative solutions, enhancing patient access to essential testing tools. The demand for accurate and user-friendly devices is on the rise, further propelling market expansion.

The United States is the primary contributor, with major players like Abbott, Dexcom, and LifeScan dominating the landscape. The competitive environment is characterized by continuous innovation and strategic partnerships among key manufacturers. As the market evolves, companies are focusing on developing advanced test strips that offer improved accuracy and convenience, ensuring they meet the growing needs of diabetic patients.

### Europe : Emerging Market with Growth Potential

Europe's blood glucose test strip market is valued at 1.5 billion, reflecting a growing demand driven by rising diabetes cases and an aging population. Regulatory frameworks are becoming more supportive, encouraging the adoption of advanced testing technologies. The region is witnessing an increase in health awareness, leading to higher demand for self-monitoring devices, which is expected to boost market growth significantly in the coming years.

Germany and the UK are leading markets, with key players like Roche and Bayer making substantial contributions. The competitive landscape is marked by innovation and collaboration among manufacturers to enhance product offerings. As the market matures, companies are focusing on integrating digital health solutions with traditional testing methods, ensuring a comprehensive approach to diabetes management.

### Asia-Pacific : Rapidly Growing Market Segment

The Asia-Pacific region, valued at 1.25 billion, is experiencing rapid growth in the blood glucose test strip market. Factors such as increasing diabetes prevalence, rising disposable incomes, and greater health awareness are driving demand. Governments are implementing initiatives to improve healthcare access, which is expected to further stimulate market growth. The region's diverse population presents unique challenges and opportunities for tailored solutions in diabetes management.

Countries like Japan and Australia are at the forefront, with significant contributions from local and international players. Companies such as Terumo and Ascensia Diabetes Care are focusing on innovation to meet the specific needs of the region. The competitive landscape is evolving, with an emphasis on affordability and accessibility, ensuring that more patients can benefit from effective glucose monitoring solutions.

### Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region currently holds a market size of 0.0 billion, indicating significant challenges in diabetes management. Factors such as limited healthcare infrastructure, lack of awareness, and high costs of [medical devices](https://www.marketresearchfuture.com/reports/medical-devices-market-2869) hinder market growth. However, there is a growing recognition of the need for improved diabetes care, which could lead to future opportunities. Governments are beginning to prioritize healthcare initiatives, aiming to enhance access to essential medical devices.

Countries like South Africa and the UAE are gradually developing their healthcare systems, with potential for growth in the blood glucose test strip market. The presence of key players is limited, but as awareness increases, companies may explore entry into this market. The competitive landscape remains underdeveloped, but the potential for growth is significant as healthcare investments rise in the region.

## Competitive Benchmarking

The Global Blood Glucose Test Strip is currently characterized by a dynamic competitive landscape, driven by increasing diabetes prevalence and the rising demand for home monitoring solutions. Key players such as Abbott (US), Roche (CH), and Dexcom (US) are strategically positioned to leverage innovation and technological advancements. Abbott (US) focuses on enhancing its product portfolio through continuous innovation, while Roche (CH) emphasizes partnerships to expand its market reach. Dexcom (US) is heavily investing in digital health solutions, which positions it favorably in a market that increasingly values connectivity and data analytics. Collectively, these strategies contribute to a competitive environment that is both innovative and responsive to consumer needs.
 
In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market structure appears moderately fragmented, with several key players holding substantial market shares. This fragmentation allows for a variety of competitive strategies, as companies seek to differentiate themselves through unique product offerings and customer engagement initiatives. The influence of major players is significant, as they set trends that smaller companies often follow, thereby shaping the overall market dynamics.
 
In January 2026, Abbott (US) announced the launch of its latest blood glucose test strip, which integrates advanced biosensor technology aimed at improving accuracy and reducing the time required for results. This strategic move is likely to enhance Abbott's competitive edge, as it addresses the growing consumer demand for rapid and reliable testing solutions. The introduction of this product not only reinforces Abbott's commitment to innovation but also positions it to capture a larger share of the market.
 
In December 2025, Roche (CH) entered into a strategic partnership with a leading digital health company to develop a comprehensive diabetes management platform. This collaboration is expected to enhance Roche's product offerings by integrating data analytics and personalized health insights, thereby improving patient outcomes. Such partnerships indicate a shift towards holistic diabetes management solutions, which could redefine how companies engage with consumers and healthcare providers.
 
In November 2025, Dexcom (US) expanded its distribution network in Asia-Pacific, aiming to increase accessibility to its continuous glucose monitoring systems. This expansion is significant as it not only broadens Dexcom's market presence but also aligns with the growing demand for advanced diabetes management tools in emerging markets. By enhancing accessibility, Dexcom is likely to strengthen its brand loyalty and customer base in these regions.
 
As of February 2026, current trends in The Global Blood Glucose Test Strip indicate a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are increasingly shaping the competitive landscape, as companies recognize the value of collaboration in driving innovation. Moving forward, competitive differentiation is expected to evolve from traditional price-based competition to a focus on technological advancements, product reliability, and supply chain efficiency. This shift underscores the importance of innovation as a key driver of market success.

## Recent News & Developments

- **Q2 2024: Ascensia Diabetes Care Launches Next-Generation CONTOUR®NEXT Blood Glucose Test Strips in the U.S.** Ascensia Diabetes Care announced the U.S. launch of its next-generation CONTOUR®NEXT blood glucose test strips, designed to deliver improved accuracy and ease of use for people with diabetes.
- **Q1 2024: Trividia Health Announces FDA Clearance for TRUE METRIX® AIR Blood Glucose Test Strips** Trividia Health received FDA clearance for its TRUE METRIX® AIR blood glucose test strips, expanding its portfolio of diabetes management solutions in the U.S. market.
- **Q2 2024: ARKRAY, Inc. Opens New Manufacturing Facility for Blood Glucose Test Strips in Minnesota** ARKRAY, Inc. inaugurated a new manufacturing facility in Minnesota to increase production capacity for its blood glucose test strips, aiming to meet growing demand in North America.
- **Q3 2024: Roche Receives CE Mark for Accu-Chek Guide Me Blood Glucose Test Strips in Europe** Roche announced it has received CE Mark approval for its Accu-Chek Guide Me blood glucose test strips, enabling commercialization across the European Union.
- **Q1 2024: BioSense Medical Secures $20 Million Series B Funding to Expand Blood Glucose Test Strip Production** BioSense Medical closed a $20 million Series B funding round to scale up manufacturing and accelerate development of its next-generation blood glucose test strips.
- **Q2 2025: AgaMatrix Announces Strategic Partnership with Medtronic for Blood Glucose Test Strip Distribution** AgaMatrix entered a strategic partnership with Medtronic to distribute its blood glucose test strips through Medtronic’s diabetes care network in select international markets.
- **Q1 2025: PTS Diagnostics Appoints New CEO to Drive Growth in Blood Glucose Test Strip Business** PTS Diagnostics announced the appointment of a new Chief Executive Officer, aiming to strengthen its leadership and accelerate growth in the blood glucose test strip segment.
- **Q2 2024: Bionime Corporation Launches Rightest GM7000 Blood Glucose Test Strips in India** Bionime Corporation launched its Rightest GM7000 blood glucose test strips in the Indian market, expanding its presence in Asia and offering advanced diabetes monitoring solutions.
- **Q3 2024: Ypsomed Receives FDA Clearance for mylife Unio Neva Blood Glucose Test Strips** Ypsomed received FDA clearance for its mylife Unio Neva blood glucose test strips, allowing the company to market the product in the United States.
- **Q1 2025: Dexcom Acquires Minority Stake in Blood Glucose Test Strip Startup GlucoTrack** Dexcom acquired a minority equity stake in GlucoTrack, a startup developing innovative blood glucose test strip technology, to support product development and potential future collaboration.
- **Q2 2025: Sinocare Receives NMPA Approval for Safe AQ Voice Blood Glucose Test Strips in China** Sinocare announced it has received approval from the National Medical Products Administration (NMPA) for its Safe AQ Voice blood glucose test strips, enabling commercial launch in China.
- **Q3 2024: Nova Biomedical Expands Blood Glucose Test Strip Production with New Facility in Ireland** Nova Biomedical opened a new manufacturing facility in Ireland to expand production capacity for its blood glucose test strips, supporting growth in the European market.

## Report Scope

| MARKET SIZE 2024 | 6.25(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 6.56(USD Billion) |
| MARKET SIZE 2035 | 10.73(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.04% (2024 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Abbott (US), Roche (CH), Bayer (DE), Dexcom (US), Terumo (JP), Ascensia Diabetes Care (DE), LifeScan (US), Nova Biomedical (US), Acon Laboratories (US) |
| Segments Covered | Application, End Use, Distribution Channel, Product Type |
| Key Market Opportunities | Integration of digital health technologies enhances user engagement in The Global Blood Glucose Test Strip. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the blood glucose test strip market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the projected market valuation of The Global Blood Glucose Test Strip by 2035?**
A: The projected market valuation is expected to reach 10.73 USD Billion by 2035.

**Q: What was the overall market valuation of The Global Blood Glucose Test Strip in 2024?**
A: The overall market valuation was 6.25 USD Billion in 2024.

**Q: What is the expected CAGR for The Global Blood Glucose Test Strip during the forecast period 2025 - 2035?**
A: The expected CAGR during this period is 5.04%.

**Q: Which companies are considered key players in The Global Blood Glucose Test Strip?**
A: Key players include Abbott, Roche, Bayer, Dexcom, Terumo, Ascensia Diabetes Care, LifeScan, Nova Biomedical, and Acon Laboratories.

**Q: What are the projected valuations for the Self Monitoring segment by 2035?**
A: The Self Monitoring segment is projected to grow from 2.5 USD Billion in 2024 to 4.25 USD Billion by 2035.

**Q: How does the Home Care segment's valuation change from 2024 to 2035?**
A: The Home Care segment is expected to increase from 1.0 USD Billion in 2024 to 1.5 USD Billion by 2035.

**Q: What is the anticipated growth for the Online Retail distribution channel by 2035?**
A: The Online Retail distribution channel is projected to grow from 1.25 USD Billion in 2024 to 2.1 USD Billion by 2035.

**Q: What are the expected valuations for Smart Test Strips by 2035?**
A: Smart Test Strips are anticipated to grow from 2.0 USD Billion in 2024 to 3.5 USD Billion by 2035.

**Q: What is the projected valuation for the Chronic Disease Management end-use segment by 2035?**
A: The Chronic Disease Management segment is expected to rise from 1.5 USD Billion in 2024 to 2.73 USD Billion by 2035.

**Q: How does the market for Continuous Glucose Monitoring Strips evolve by 2035?**
A: The market for Continuous Glucose Monitoring Strips is projected to increase from 1.75 USD Billion in 2024 to 3.0 USD Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/global-blood-glucose-test-strip-market-976*